Can epilepsy be treated by antibiotics?
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
There is mounting evidence for the role of the gut microbiota and gut-brain interactions in neurological diseases. We present six patients with drug-resistant epilepsy who attained temporary seizure freedom during antibiotic treatment. The effect on seizure frequency waned within 2 weeks after cessation of antibiotic treatment. We hypothesized that antibiotic treatments may have a short-term effect, through gut microbiota disruption, on gut-brain interactions and ultimately seizure frequency. This observed impact of antibiotics on seizure frequency hints at a possible role of the gut microbiota in epilepsy and its manifestations. This begs the question: can epilepsy be treated by antibiotics? Or perhaps in a broader sense: can alterations in the gut microbiota be used as a treatment modality in drug-resistant epilepsy? This concept and the six intriguing cases provide interesting leads for epilepsy management.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Six patients with drug-resistant epilepsy attained temporary seizure freedom during antibiotic treatment.”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [368]
In the citing paper
“While the use of macrolide antibiotics may have increased the serum concentration of ASDs, thus augmenting their action, it is also possible that the observed effect was mediated by the influence on the gut microbiota [368].”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [368]
Citations
Cites
The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet
Olson, C. A., Vuong, H. E., Yano, J. M., Liang, Q. Y., Nusbaum, D. J., & Hsiao, E. Y. (2018) · Cell · doi:10.1016/j.cell.2018.04.027 · Cited by 1,057
Kwan, P., Schachter, S. C., & Brodie, M. J. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1004418 · Cited by 1,052
Arroyo, S., Rumià, J., Martínez, I., & Ribalta, T. (1998) · PubMed · Cited by 652
The gut microbiome in human neurological disease: A review
Tremlett, H., Bauer, K. C., Appel‐Cresswell, S., Finlay, B. B., & Waubant, E. (2017) · Annals of Neurology · doi:10.1002/ana.24901 · Cited by 535
Too much of a good thing: a retrospective study of β-lactam concentration–toxicity relationships
Imani, S., Buscher, H., Marriott, D., Gentili, S., & Sandaradura, I. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx209 · Cited by 320
Xie, G., Zhou, Q., Qiu, C.-Z., Dai, W.-K., Wang, H.-P., Li, Y.-H., Liao, J.-X., Lu, X.-G., Lin, S.-F., Ye, J.-H., et al. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i33.6164 · Cited by 291
The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet
Olson, C. A., Vuong, H. E., Yano, J. M., Liang, Q. Y., Nusbaum, D. J., & Hsiao, E. Y. (2018) · Cell · doi:10.1016/j.cell.2018.06.051 · Cited by 224
Drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors
Supuran, C. T. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2016.1154534 · Cited by 129
Cited by
The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders
Socała, K., Doboszewska, U., Szopa, A., Serefko, A., Włodarczyk, M., Zielińska, A., Poleszak, E., Fichna, J., & Wlaź, P. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105840 · Cited by 857
Antibiotics, gut microbiota, and Alzheimer’s disease
Angelucci, F., Cechova, K., Amlerova, J., & Hort, J. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1494-4 · Cited by 454
Bacteriocin-Producing Probiotic Lactic Acid Bacteria in Controlling Dysbiosis of the Gut Microbiota
Anjana, & Tiwari, S. K. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.851140 · Cited by 264
The gut microbiome and epilepsy
Dahlin, M., & Prast-Nielsen, S. (2019) · eBioMedicine · doi:10.1016/j.ebiom.2019.05.024 · Cited by 190
“This effect vanishedwithin twoweeks of cessation of the treatment, hypothetically due to a recovery of certain gut microorganisms [24] however other underlyingmechanisms cannot be ruled out.”
BackgroundMicrobiota–Gut–Brain Axis and Epilepsy: A Review on Mechanisms and Potential Therapeutics
Ding, M., Lang, Y., Shu, H., Shao, J., & Cui, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.742449 · Cited by 169
Metadata
- Authors
- Braakman, H. M. H., & van Ingen, J.
- Affiliations
- Maastricht University Medical Centre (NL)
- Corresponding author
- Braakman, Hilde M. H.
- Venue
- Journal of Neurology
- Published
- 2018-06-21
- Volume
- 265
- Issue
- 8
- Pages
- 1934-1936
- ISSN
- 0012-1037 (ISSN-L)
- 0340-5354
- 1432-1459
- OpenAlex
- W2809258037
- Cited by
- 70
- References
- 8
- Citations by year
- 2026: 1 · 2025: 9 · 2024: 6 · 2023: 10 · 2022: 14 · 2021: 16 · 2020: 7 · 2019: 6
- FWCI
- 5.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- drug-resistant epilepsy, antibiotic therapy, gut microbiota, gut-brain axis, seizure frequency, microbiota-targeted therapy, epilepsy management
- MeSH terms
- Gastrointestinal Microbiome, Drug Resistant Epilepsy, Adolescent, Anti-Bacterial Agents, Anticonvulsants, Child, Female, Humans, Male, Seizures, Diet, Ketogenic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Can epilepsy be treated by antibiotics? https://app.cochat.ai/papers/10.1007/s00415-018-8943-3
- The paper
- Braakman, H. M. H., & van Ingen, J. (2018). Can epilepsy be treated by antibiotics? Journal of Neurology. https://doi.org/10.1007/s00415-018-8943-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.